12 listopada 2019
Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019), November 6–10, National Harbor, MD, USA
Rok
2019
Cel
STING, A2A/A2B
Zasoby na tej stronie
Pobierz zasoby
- plik pdf
"Novel dual A2A /A2B adenosine receptor antagonists for cancer immunotherapy in vitro characterization"
Pobierz - plik pdf
"Development and characterization of next generation small molecule STING agonists"
Pobierz